Michael Contarino - Odyssey Group Head Devel
| ODYY Stock | USD 0.01 0 9.09% |
Insider
Michael Contarino is Head Devel of Odyssey Group International
| Age | 68 |
| Phone | 702 780 6559 |
| Web | https://www.odysseyhealthinc.com |
Odyssey Group Management Efficiency
The company has return on total asset (ROA) of (6.0814) % which means that it has lost $6.0814 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3469) %, meaning that it created substantial loss on money invested by shareholders. Odyssey Group's management efficiency ratios could be used to measure how well Odyssey Group manages its routine affairs as well as how well it operates its assets and liabilities.Odyssey Group International currently holds 1.56 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Odyssey Group Intern has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Odyssey Group until it has trouble settling it off, either with new capital or with free cash flow. So, Odyssey Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Odyssey Group Intern sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Odyssey to invest in growth at high rates of return. When we think about Odyssey Group's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Ran Daniel | Nano X Imaging | 57 | |
| Michael Freeman | Viemed Healthcare | N/A | |
| Michael CRT | Viemed Healthcare | 48 | |
| Brett Wall | Medtronic PLC | 59 | |
| John Liddicoat | Medtronic PLC | 56 | |
| Sally Saba | Medtronic PLC | N/A | |
| Ran Poliakine | Nano X Imaging | 55 | |
| Brad Lerman | Medtronic PLC | 63 | |
| James Dara | Nano X Imaging | 55 | |
| Micah Mitchell | Myomo Inc | 49 | |
| MSc MD | Medtronic PLC | N/A | |
| William MD | Viemed Healthcare | 67 | |
| Trae Fitzgerald | Viemed Healthcare | 37 | |
| William Compton | Integra LifeSciences Holdings | N/A | |
| Lydia Edwards | Nano X Imaging | N/A | |
| Maria Platsis | Integra LifeSciences Holdings | N/A | |
| Gilad Yron | Nano X Imaging | 51 | |
| Casey Hoyt | Viemed Healthcare | 48 | |
| Tal Shank | Nano X Imaging | 46 | |
| Sean Lennon | Medtronic PLC | N/A | |
| Ilung Kim | Nano X Imaging | 65 | |
Management Performance
| Return On Equity | -0.35 | |||
| Return On Asset | -6.08 |
Odyssey Group Intern Leadership Team
Elected by the shareholders, the Odyssey Group's board of directors comprises two types of representatives: Odyssey Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Odyssey. The board's role is to monitor Odyssey Group's management team and ensure that shareholders' interests are well served. Odyssey Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Odyssey Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Contarino, Head Devel | ||
| Erik Emerson, Chief Officer | ||
| Christine Farrell, Controller CFO | ||
| Joseph Redmond, Pres Chairman | ||
| Greg Gironda, Chief Officer |
Odyssey Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Odyssey Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.35 | |||
| Return On Asset | -6.08 | |||
| Current Valuation | 12.08 M | |||
| Shares Outstanding | 75.59 M | |||
| Shares Owned By Insiders | 27.53 % | |||
| Price To Book | 0.77 X | |||
| EBITDA | (7.61 M) | |||
| Net Income | (8.44 M) | |||
| Cash And Equivalents | 266.3 K | |||
| Total Debt | 1.56 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Odyssey Pink Sheet Analysis
When running Odyssey Group's price analysis, check to measure Odyssey Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Odyssey Group is operating at the current time. Most of Odyssey Group's value examination focuses on studying past and present price action to predict the probability of Odyssey Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Odyssey Group's price. Additionally, you may evaluate how the addition of Odyssey Group to your portfolios can decrease your overall portfolio volatility.